While a number of studies implicate increased IGF-1 in CRC patients or a positive association of elevated IGF-1 with CRC risk [40,41,42], others demonstrated lower levels of this peptide in CRC [43,44,45]. The gene discussed is IGF1; the disease is colorectal carcinoma.